Open for inclusion

Dendritic cell-based active immunotherapy of patients with acute myeloid leukemia using autologous cells transfected with RNA encoding two different leukemia-associated antigens

Cancer type: Hematological malignancies

Phase: I/II

Principal Investigator: Fløisand Yngvar

Country: NO

Keywords: Norway, Oslo, DC vaccination, AML

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02405338?term=Medigene&rank=8